Preoperative evaluation of pancreatic cancer: Comparison of gadolinium-enhanced dynamic MRI with MR cholangiopancreatography versus MDCT

Journal of Magnetic Resonance Imaging

Volumn 30, Issue 3, 2009, Pages 586-595

  Hee, Sun Park ^a,b   Jeong, Min Lee ^a   Hei, Kyung Choi ^a   Sung, Hyun Hong ^c   Joon, Koo Han ^a   Byung, Ihn Choi ^a  

^a Seoul National University College of Medicine   (South Korea)

^b Konkuk University Hospital   (South Korea)

^c The Catholic University of Korea   (South Korea)

Author keywords

Magnetic resonance cholangiopancreaticography; Magnetic resonance imaging; Multidetector row CT; Pancreas neoplasm

Indexed keywords

GADOLINIUM;

ADULT; AGED; ARTICLE; CANCER INVASION; CANCER SURGERY; CONTRAST ENHANCEMENT; CONTROLLED STUDY; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; INTERMETHOD COMPARISON; LYMPH NODE METASTASIS; MAGNETIC RESONANCE CHOLANGIOPANCREATOGRAPHY; MAJOR CLINICAL STUDY; MALE; METASTASIS; MULTIDETECTOR COMPUTED TOMOGRAPHY; NUCLEAR MAGNETIC RESONANCE IMAGING; PANCREAS CARCINOMA; PREOPERATIVE EVALUATION; PRIORITY JOURNAL; THREE DIMENSIONAL IMAGING;

ADULT; AGED; AGED, 80 AND OVER; CHOLANGIOPANCREATOGRAPHY, MAGNETIC RESONANCE; CONTRAST MEDIA; FEMALE; HUMANS; IMAGE ENHANCEMENT; IMAGING, THREE-DIMENSIONAL; IOHEXOL; MAGNETIC RESONANCE IMAGING; MALE; MEGLUMINE; MIDDLE AGED; NEOPLASM STAGING; OBSERVER VARIATION; ORGANOMETALLIC COMPOUNDS; PANCREAS; PANCREATIC NEOPLASMS; PREOPERATIVE CARE; REPRODUCIBILITY OF RESULTS; RETROSPECTIVE STUDIES; ROC CURVE; SENSITIVITY AND SPECIFICITY; TOMOGRAPHY, X-RAY COMPUTED;

EID: 69449087641     PISSN: 10531807     EISSN: 15222586     Source Type: Journal    
DOI: 10.1002/jmri.21889     Document Type: Article

References (42)

1. Wagner M, Dikopoulos N, Kulli C, Friess H, Buchler MW. Standard surgical treatment in pancreatic cancer. Ann Oncol 1999;10(Suppl 4):247-251. (Pubitemid 29333443)
2. Lillemoe KD. Current management of pancreatic carcinoma. Ann Surg 1995;221:133-148.
3. Rosewicz S, Wiedenmann B. Pancreatic carcinoma. Lancet 1997; 349:485-489.
4. American Cancer Society. Cancer facts & figures 2002. Atlanta, GA: American Cancer Society 2002.
5. Warshaw AL, Gu ZY, Wittenberg J, Waltman AC. Preoperative staging and assessment of resectability of pancreatic cancer. Arch Surg 1990;125:230-233. (Pubitemid 20060650)
6. Trede M, Schwall G, Saeger HD. Survival after pancreatoduodenectomy. 118 consecutive resections without an operative mortality. Ann Surg 1990;211:447-458.
7. Warshaw AL, Fernandez-del Castillo C. Pancreatic carcinoma. N Engl J Med 1992;326:455-465.
8. DeWitt J, Devereaux B, Chriswell M, et al. Comparison of endoscopic ultrasonography and multidetector computed tomography for detecting and staging pancreatic cancer. Ann Intern Med 2004; 141:753-763. (Pubitemid 39524913)
9. Yeo CJ, Cameron JL, Sohn TA, et al. Six hundred fifty consecutive pancreaticoduodenectomies in the 1990s: pathology, complications, and outcomes. Ann Surg 1997;226:248-257; discussion 257-260.
10. Valls C, Andia E, Sanchez A, et al. Dual-phase helical CT of pancreatic adenocarcinoma: assessment of resectability before surgery. AJR Am J Roentgenol 2002;178:821-826. (Pubitemid 34250214)
11. Schima W, Fugger R, Schober E, et al. Diagnosis and staging of pancreatic cancer: comparison of mangafodipir trisodium-enhanced MR imaging and contrast-enhanced helical hydro-CT. AJR Am J Roentgenol 2002;179:717-724. (Pubitemid 34919588)
12. Lu DS, Reber HA, Krasny RM, Kadell BM, Sayre J. Local staging of pancreatic cancer: criteria for unresectability of major vessels as revealed by pancreatic-phase, thin-section helical CT. AJR Am J Roentgenol 1997;168:1439-1443. (Pubitemid 27232661)
13. Sironi S, De Cobelli F, Zerbi A, et al. Pancreatic adenocarcinoma: assessment of vascular invasion with high-field MR imaging and a phased-array coil. AJR Am J Roentgenol 1996;167:997-1001. (Pubitemid 26322262)
14. Bipat S, Phoa SS, van Delden OM, et al. Ultrasonography, computed tomography and magnetic resonance imaging for diagnosis and determining resectability of pancreatic adenocarcinoma: a meta-analysis. J Comput Assist Tomogr 2005;29:438-445. (Pubitemid 41060274)
15. Parsons CM, Sutcliffe JL, Bold RJ. Preoperative evaluation of pancreatic adenocarcinoma. J Hepatobiliary Pancreat Surg 2008;15: 429-435.
16. Nichols MT, Russ PD, Chen YK. Pancreatic imaging: current and emerging technologies. Pancreas 2006;33:211-220. (Pubitemid 44470134)
17. McNulty NJ, Francis IR, Platt JF, Cohan RH, Korobkin M, Gebremariam A. Multi - detector row helical CT of the pancreas: effect of contrast-enhanced multiphasic imaging on enhancement of the pancreas, peripancreatic vasculature, and pancreatic adenocarcinoma. Radiology 2001;220:97-102. (Pubitemid 32577966)
18. Smith SL, Rajan PS. Imaging of pancreatic adenocarcinoma with emphasis on multidetector CT. Clin Radiol 2004;59:26-38.
19. Prokesch RW, Chow LC, Beaulieu CF, et al. Local staging of pancreatic carcinoma with multi-detector row CT: use of curved planar reformations initial experience. Radiology 2002;225:759-765.
20. Fletcher JG, Wiersema MJ, Farrell MA, et al. Pancreatic malignancy: value of arterial, pancreatic, and hepatic phase imaging with multi-detector row CT. Radiology 2003;229:81-90.
21. Rofsky NM, Lee VS, Laub G, et al. Abdominal MR imaging with a volumetric interpolated breath-hold examination. Radiology 1999; 212:876-884. (Pubitemid 29410996)
22. Birchard KR, Semelka RC, Hyslop WB, et al. Suspected pancreatic cancer: evaluation by dynamic gadolinium-enhanced 3D gradient-echo MRI. AJR Am J Roentgenol 2005;185:700-703.
23. Irie H, Honda H, Kaneko K, Kuroiwa T, Yoshimitsu K, Masuda K. Comparison of helical CT and MR imaging in detecting and staging small pancreatic adenocarcinoma. Abdom Imaging 1997; 22:429-433. (Pubitemid 27272825)
24. Ichikawa T, Haradome H, Hachiya J, et al. Pancreatic ductal adenocarcinoma: preoperative assessment with helical CT versus dynamic MR imaging. Radiology 1997;202:655-662. (Pubitemid 27093433)
25. Megibow AJ, Zhou XH, Rotterdam H, et al. Pancreatic adenocarcinoma: CT versus MR imaging in the evaluation of resectability - report of the Radiology Diagnostic Oncology Group. Radiology 1995;195:327-332.
26. Romijn MG, Stoker J, van Eijck CH, van Muiswinkel JM, Torres CG, Lameris JS. MRI with mangafodipir trisodium in the detection and staging of pancreatic cancer. J Magn Reson Imaging 2000;12: 261-268. (Pubitemid 30612870)
27. Nishiharu T, Yamashita Y, Abe Y, et al. Local extension of pancreatic carcinoma: assessment with thin-section helical CT versus with breath-hold fast MR imaging-ROC analysis. Radiology 1999; 212:445-452. (Pubitemid 29356565)
28. Keogan MT, McDermott VG, Paulson EK, et al. Pancreatic malignancy: effect of dual-phase helical CT in tumor detection and vascular opacification. Radiology 1997;205:513-518. (Pubitemid 27467334)
29. Mehmet Erturk S, Ichikawa T, Sou H, et al. Pancreatic adenocarcinoma: MDCT versus MRI in the detection and assessment of locoregional extension. J Comput Assist Tomogr 2006;30:583-590. (Pubitemid 44091512)
30. Park HS, Lee JM, Choi JY, et al. Preoperative evaluation of bile duct cancer: MRI combined with MR cholangiopancreatography versus MDCT with direct cholangiography. AJR Am J Roentgenol 2008; 190:396-405.
31. Kim YK, Kim CS, Kwak HS, Lee JM. Three-dimensional dynamic liver MR imaging using sensitivity encoding for detection of hepatocellular carcinomas: comparison with superparamagnetic iron oxide-enhanced mr imaging. J Magn Reson Imaging 2004; 20:826-837. (Pubitemid 39426079)
32. Roche CJ, Hughes ML, Garvey CJ, et al. CT and pathologic assessment of prospective nodal staging in patients with ductal adenocarcinoma of the head of the pancreas. AJR Am J Roentgenol 2003;180:475-480.
33. Sheridan MB, Ward J, Guthrie JA, et al. Dynamic contrast-enhanced MR imaging and dual-phase helical CT in the preoperative assessment of suspected pancreatic cancer: a comparative study with receiver operating characteristic analysis. AJR Am J Roentgenol 1999;173:583-590. (Pubitemid 29395272)
34. Raut CP, Tseng JF, Sun CC, et al. Impact of resection status on pattern of failure and survival after pancreaticoduodenectomy for pancreatic adenocarcinoma. Ann Surg 2007;246:52-60.
35. Katz MH, Pisters PW, Evans DB, et al. Borderline resectable pancreatic cancer: the importance of this emerging stage of disease. J Am Coll Surg 2008;206:833-846; discussion 846-1838
36. Gohde SC, Toth J, Krestin GP, Debatin JF. Dynamic contrast-enhanced FMPSPGR of the pancreas: impact on diagnostic performance. AJR Am J Roentgenol 1997;168:689-696. (Pubitemid 27089933)
37. Obuz F, Dicle O, Coker A, Sagol O, Karademir S. Pancreatic adenocarcinoma: detection and staging with dynamic MR imaging. Eur J Radiol 2001;38:146-150. (Pubitemid 32396822)
38. Elsayes KM, Narra VR, Abou El Abbass HA, Aly TS, Radwan SM, Chen ZM. Pancreatic tumors: diagnostic patterns by 3D gradient-echo post contrast magnetic resonance imaging with pathologic correlation. Curr Probl Diagn Radiol 2006;35:125-139.
39. Kim JK, Altun E, Elias J, Jr., Pamuklar E, Rivero H, Semelka RC. Focal pancreatic mass: distinction of pancreatic cancer from chronic pancreatitis using gadolinium-enhanced 3D-gradient-echo MRI. J Magn Reson Imaging 2007;26:313-322. (Pubitemid 47257729)
40. Elias J Jr, Semelka RC, Altun E, et al. Pancreatic cancer: correlation of MR findings, clinical features, and tumor grade. J Magn Reson Imaging 2007;26:1556-1563. (Pubitemid 350291284)
41. Fischer U, Vosshenrich R, Horstmann O, et al. Preoperative local MRI-staging of patients with a suspected pancreatic mass. Eur Radiol 2002;12:296-303. (Pubitemid 36940063)
42. Rieber A, Tomczak R, Nussle K, Klaus H, Brambs HJ. MRI with mangafodipir trisodium in the detection of pancreatic tumours: comparison with helical CT. Br J Radiol 2000;73:1165-1169.